The facility in Kabul, Afghanistan, is proving to be a key factor in the worldwide supply network for Abacavir Sulphate drug substance. This Afghan manufacturing capability represents a considerable step ahead for the Afghan pharmaceutical sector and offers a unique opportunity to decrease need o